These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 6468709

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. LDH isozymes in transplantable hamster tumours with different histogenesis and differentiation.
    Nicolov IG, Chernozemsky IN, Petkova-Bocharova T, Stoichev II.
    Arch Geschwulstforsch; 1981; 51(2):174-8. PubMed ID: 7271428
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. LDH isoenzymes in the serum of patients with malignant diseases.
    Roguljić A, Demirović J.
    Acta Med Iugosl; 1980 Nov; 34(4):315-24. PubMed ID: 7468308
    [No Abstract] [Full Text] [Related]

  • 5. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Study of the activity and isoenzyme spectrum of serum lactate dehydrogenase in mycosis fungoides].
    Kazakov AV, Mishchenko BP, Korovnikov KA.
    Vestn Dermatol Venerol; 1973 May; 47(5):51-4. PubMed ID: 4755964
    [No Abstract] [Full Text] [Related]

  • 8. [Activity and distribution of beta-glucuronidase and lactate dehydrogenase in human and transplantable melanomas of the mouse and golden hamster].
    Beyer C, Wohlrab W.
    Dermatol Monatsschr; 1982 Jul; 168(7):483-7. PubMed ID: 7128882
    [No Abstract] [Full Text] [Related]

  • 9. [Laboratory markers of melanoma progression].
    Bánfalvi T, Edesné MB, Gergye M, Udvarhelyi N, Orosz Z, Gilde K, Kremmer T, Ottó S, Tímár J.
    Magy Onkol; 2003 Jul; 47(1):89-104. PubMed ID: 12704461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.
    Deichmann M, Benner A, Waldmann V, Bock M, Jäckel A, Näher H.
    J Exp Clin Cancer Res; 2000 Sep; 19(3):301-7. PubMed ID: 11144523
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L, Situm M, Buljan M, Poduje S, Sebetić K.
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High serum galectin-3 in advanced melanoma: preliminary results.
    Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, Petein M, Vanhaeverbeek M, Ghanem G, Heenen M.
    Clin Exp Dermatol; 2006 Jan; 31(1):105-9. PubMed ID: 16309497
    [Abstract] [Full Text] [Related]

  • 16. S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase.
    Krähn G, Kaskel P, Sander S, Waizenhöfer PJ, Wortmann S, Leiter U, Peter RU.
    Anticancer Res; 2001 Jan; 21(2B):1311-6. PubMed ID: 11396205
    [Abstract] [Full Text] [Related]

  • 17. Microchip-based capillary electrophoresis for determination of lactate dehydrogenase isoenzymes.
    Zhuang GS, Liu J, Jia CP, Jin QH, Zhao JL, Wang HM.
    J Sep Sci; 2007 Jun; 30(9):1350-6. PubMed ID: 17623478
    [Abstract] [Full Text] [Related]

  • 18. Lactate dehydrogenase in dermatology practice.
    Livesey A, Garty F, Shipman AR, Shipman KE.
    Clin Exp Dermatol; 2020 Jul; 45(5):539-543. PubMed ID: 31755143
    [Abstract] [Full Text] [Related]

  • 19. LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).
    Agarwala SS, Keilholz U, Gilles E, Bedikian AY, Wu J, Kay R, Stein CA, Itri LM, Suciu S, Eggermont AM.
    Eur J Cancer; 2009 Jul; 45(10):1807-14. PubMed ID: 19419855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.